Phase I/II study of treatment with matured dendritic cells with or without low dose IL-2 in patients with disseminated melanoma

Background In the present study, we have examined whether treatment of patients with metastatic melanoma with matured dendritic cell (DC) vaccines with or without low dose IL-2 may improve treatment outcomes. Methods Sixteen patients received DC vaccines (DCs) sensitized with autologous melanoma lys...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer Immunology, Immunotherapy Immunotherapy, 2008-07, Vol.57 (7), p.1039-1051
Hauptverfasser:	Hersey, P., Halliday, G. M., Farrelly, M. L., DeSilva, C., Lett, M., Menzies, S. W.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Antineoplastic agents Biological and medical sciences Cancer Research Cancer Vaccines - therapeutic use Dendritic Cells - immunology Dendritic Cells - transplantation Dermatology Female Humans Immunology Immunotherapy Immunotherapy, Adoptive Interleukin-2 - immunology Interleukin-2 - therapeutic use Male Medical sciences Medicine Medicine & Public Health Melanoma - immunology Melanoma - secondary Melanoma - therapy Middle Aged Oncology Original Original Article Pharmacology. Drug treatments Skin Neoplasms - immunology Skin Neoplasms - pathology Skin Neoplasms - therapy Tumors of the skin and soft tissue. Premalignant lesions
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!